£43.6M
The investment round was led by Ventura Capital and will accelerate international deployment of the company's diagnostic platform.
DnaNudge provides consumer genetics testing and rapid medical diagnostics.
DnaNudge develops consumer genetics testing and medical diagnostics technology that combines DNA profiling with lifestyle factors. Its portable platform delivers rapid PCR testing for infectious diseases and personalised nutrition guidance.
Chris Toumazou
CEO and co-founder
Chris brings extensive founding and academic experience, serving as a regius professor and director at Imperial College London alongside founding ventures including DnaNudge, DNA Electronics, and Toumaz Ltd.
LinkedInThe investment round was led by Ventura Capital and will accelerate international deployment of the company's diagnostic platform.